Hostname: page-component-7c8c6479df-hgkh8 Total loading time: 0 Render date: 2024-03-28T09:17:42.330Z Has data issue: false hasContentIssue false

Folate Deficiency in Depressive Illness

Published online by Cambridge University Press:  29 January 2018

E. H. Reynolds
Affiliation:
The National Hospital for Nervous Diseases, Queen Square, London, W.C.1, and the M.R.C. Neuropsychiatric Research Unit, Carshalton, and West Park Hospital, Epsom, Surrey
J. M. Preece
Affiliation:
West Park Hospital, Epsom, Surrey
J. Bailey
Affiliation:
The Neuropsychiatric Research Unit, Carshalton, and West Park, Epsom, Surrey
Alec Coppen
Affiliation:
The M.R.C. Neuropsychiatric Research Unit, Carshalton, and West Park Hospital, Epsom, Surrey

Extract

Two reports have shown that a substantial proportion of patients suffering from various psychiatric syndromes have low serum folate concentrations (Hunter, Jones Jones and Matthews, 1967; Carney, 1967). The present investigation was concerned to examine further the prevalence of low serum folate in a series of depressive patients on admission to hospital. As folate deficiency contributes to the development of mental symptoms in epileptic patients (Reynolds, 1968), we also examined the relationship of low serum folate concentrations to the severity of the depressive illness, certain personality traits, and the response to anti-depressant treatment. The relationship of low serum folate to variables which could influence it such as diet and drugs was also examined. In a proportion of these patients serum folate measurements were repeated just before the patient's discharge. Serum B12 concentrations were also estimated.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1970 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baker, H., Herbert, V., Frank, O., Pasher, I., Hutner, S. H., Wasserman, L. R., and Sobotka, H. (1959). ‘A microbiologic method for detecting folic acid deficiency in man.’ Clin, Chem., 5, 275–80.Google Scholar
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., Erbaugh, J. (1961). ‘An inventory for measuring depression.’ Arch. gen. Psychiat., 4, 561–71.Google Scholar
Carney, M. W. P. (1967). ‘Serum folate values in 423 psychiatric patients.’ Brit. med. J., 4, 512–16.Google Scholar
Coppen, A., and Metcalfe, M. (1965). ‘Effect of a depressive illness on M.P.I. scores.’ Brit. J. Psychiat., 3, 236–9.Google Scholar
Coppen, A. (1966). ‘The Marke-Nyman temperament scale: an English translation.’ Brit. J. med. Psychol., 39, 5559.Google Scholar
Coppen, A. (1968). ‘Depressed states and indolealkylamines.’ Advances in Pharmacology, 6, 283–91.CrossRefGoogle ScholarPubMed
Coppen, A., Shaw, D. M., Herzberg, B., and Maggs, R. (1967). ‘Tryptophan in the treatment of depression.’ Lancet, ii, 1178–80.Google Scholar
Edwin, E., Holten, K., Norum, K. R., Schrumpf, A., and Skaug, O. E. (1965). ‘Vitamin B12 hypovitaminosis in mental diseases.’ Acta med. Scand., 177, 689–99.Google Scholar
Eysenck, H. J., and Eysenck, S. B. G. (1964). Manual of the Eysenck Personality Inventory. London.Google Scholar
Girdwood, R. H., Thomson, A. D., and Williamson, J. (1967). ‘Folate status in the elderly.’ Brit. med. J., ii, 670–2.Google Scholar
Henderson, J. G., Strachan, R. W., Beck, J. S., Dawson, A., and Daniel, M. (1966). ‘The antigastric-antibody test as a screening procedure for vitamin B12 deficiency in psychiatric practice.’ Lancet, ii, 809–13.Google Scholar
Hunter, R., Jones, M., Jones, T. G., and Matthews, D. M. (1967). ‘Serum B12 and folate concentrations in mental patients.’ Brit. J. Psychiat., 113, 1291–5.CrossRefGoogle Scholar
Lovenberg, W., Jequire, E., and Sjoerdsma, A. (1968). ‘Tryptophan hydroxylation in mammalian systems.’ Advances in Pharmacology, 6, 2136.CrossRefGoogle ScholarPubMed
Metcalfe, M., and Goldman, E. (1965). ‘Validation of an inventory for measuring depression.’ Brit. J. Psychiat., 111, 240–2.Google Scholar
Reynolds, E. H., Chanarin, I., Milner, G., and Matthews, D. M. (1966). ‘Anticonvulsant therapy, folic acid and vitamin B12 metabolism and mental symptoms.’ Epilepsia, 7, 261–70.Google Scholar
Reynolds, E. H. (1967a). ‘Effects of folic acid on the mental state and fit frequency of drug-treated epileptic patients.’ Lancet, i, 1086–8.Google Scholar
Reynolds, E. H. (1967b). ‘Vitamin B12 and folate deficiencies.’ Brit. J. Psychiat., 113, 681–3.Google Scholar
Reynolds, E. H. (1968). ‘Mental effects of anticonvulsants and folate metabolism.’ Brain, 91, 197214.Google Scholar
Schildkraut, J. J. (1965). ‘The catecholamine hypothesis of affective disorders: a review of supporting evidence.’ Amer. J. Psychiat., 122, 509–22.Google Scholar
Udenfriend, S. (1966). ‘Biosynthesis of the sympathetic neurotransmitter, norepinephrine.’ The Harvey Lectures, Series 60, 5783.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.